Chemotherapy and Radiation
721 articles
Testing the Effect of a Malaria Drug on Standard Treatment
A clinical trial tests whether a malaria drug can make standard chemotherapy for advanced pancreatic cancer more effective.
Pancreatic Cancer Caught Early by Chance
Sandra Wilke chose her pancreatic cancer treatment of chemotherapy and pancreatectomy with an eye to her quality of life. She joined the tumor registry to learn more and help others.
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
Using a Virus to Infect and Destroy Pancreatic Cancer Cells
A clinical trial tests the combination of standard chemotherapy plus a common cold virus that has been modified to kill cancer cells.
Testing the Effectiveness of Immunotherapy Added to a New Drug Combination
Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.
A New Drug to Target Cancer Cell Enzymes
Researchers are testing a drug that targets the enzymes that help generate energy for cell division, to disrupt pancreatic cancer cell multiplication.
Pancreatic Cancer During the Pandemic
Barbara Wojciechowski was diagnosed with pancreatic cancer as the pandemic was rising, affecting her family support during treatment.
BRCA Mutation Determines My Pancreatic Cancer Treatment
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
More Effective Treatment for Metastatic Pancreatic Cancer
A worldwide clinical trial is testing a new drug combined with standard treatment, for patients with metastatic pancreatic cancer.
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.
Recently Diagnosed
In Treatment
Stay Fit During Cancer Treatment
Researcher Christina Dieli-Conwright discusses the benefits of exercise during pancreatic cancer treatments, and ways patients can stay fit.